These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35854648)

  • 1. Treating ADHD and Comorbid Anxiety in Children: A Guide for Clinical Practice.
    León-Barriera R; Ortegon RS; Chaplin MM; Modesto-Lowe V
    Clin Pediatr (Phila); 2023 Jan; 62(1):39-46. PubMed ID: 35854648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the use of atomoxetine for management of comorbid anxiety disorders in children and adolescents with attention-deficit hyperactivity disorder.
    Khoodoruth MAS; Ouanes S; Khan YS
    Res Dev Disabil; 2022 Sep; 128():104275. PubMed ID: 35691145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative review.
    Golubchik P; Weizman A
    Int Clin Psychopharmacol; 2021 Jan; 36(1):1-11. PubMed ID: 33086253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.
    Geller D; Donnelly C; Lopez F; Rubin R; Newcorn J; Sutton V; Bakken R; Paczkowski M; Kelsey D; Sumner C
    J Am Acad Child Adolesc Psychiatry; 2007 Sep; 46(9):1119-1127. PubMed ID: 17712235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response inhibition and emotional cognition improved by atomoxetine in children and adolescents with ADHD: The ACTION randomized controlled trial.
    Griffiths KR; Leikauf JE; Tsang TW; Clarke S; Hermens DF; Efron D; Williams LM; Kohn MR
    J Psychiatr Res; 2018 Jul; 102():57-64. PubMed ID: 29674270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness.
    Waxmonsky J
    Curr Opin Pediatr; 2003 Oct; 15(5):476-82. PubMed ID: 14508296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: effects on treatment.
    Manassis K
    Expert Rev Neurother; 2007 Aug; 7(8):981-8. PubMed ID: 17678493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atomoxetine in Attention-Deficit/Hyperactivity Disorder in Children With and Without Comorbid Mood Disorders.
    Shaker NM; Osama Y; Barakat DH; Abdelgawad AA; Abdel Aziz K; Aly El-Gabry D
    J Child Adolesc Psychopharmacol; 2021 Jun; 31(5):332-341. PubMed ID: 34143680
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and Management of Comorbid Anxiety and ADHD in Pediatric Primary Care.
    Janiczak D; Perez-Reisler M; Ballard R
    Pediatr Ann; 2020 Oct; 49(10):e436-e439. PubMed ID: 33034659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial investigation of a non-stimulant in attention deficit hyperactivity disorder (ACTION): rationale and design.
    Tsang TW; Kohn MR; Hermens DF; Clarke SD; Clark CR; Efron D; Cranswick N; Lamb C; Williams LM
    Trials; 2011 Mar; 12():77. PubMed ID: 21396130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.
    Kratochvil CJ; Newcorn JH; Arnold LE; Duesenberg D; Emslie GJ; Quintana H; Sarkis EH; Wagner KD; Gao H; Michelson D; Biederman J
    J Am Acad Child Adolesc Psychiatry; 2005 Sep; 44(9):915-24. PubMed ID: 16113620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the treatment of anxiety in children with Attention-Deficit/Hyperactivity Disorder (ADHD) using cognitive behavioral therapy improve child and family outcomes? Protocol for a randomized controlled trial.
    Sciberras E; Efron D; Patel P; Mulraney M; Lee KJ; Mihalopoulos C; Engel L; Rapee RM; Anderson V; Nicholson JM; Schembri R; Hiscock H
    BMC Psychiatry; 2019 Nov; 19(1):359. PubMed ID: 31722690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and Treatment of Adult ADHD Comorbid with Mood or Anxiety Disorders].
    Okada T
    Seishin Shinkeigaku Zasshi; 2015; 117(9):768-74. PubMed ID: 26721070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive-Behavioral Therapy for Children With Anxiety and Comorbid Attention-Deficit/Hyperactivity Disorder.
    Gould KL; Porter M; Lyneham HJ; Hudson JL
    J Am Acad Child Adolesc Psychiatry; 2018 Jul; 57(7):481-490.e2. PubMed ID: 29960693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study.
    Gabriel A; Violato C
    Atten Defic Hyperact Disord; 2011 Dec; 3(4):319-26. PubMed ID: 21833565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
    Párraga HC; Párraga MI; Harris DK
    Int J Psychiatry Med; 2007; 37(4):415-24. PubMed ID: 18441629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.
    Halldorsdottir T; Ollendick TH; Ginsburg G; Sherrill J; Kendall PC; Walkup J; Sakolsky DJ; Piacentini J
    J Clin Child Adolesc Psychol; 2015; 44(6):985-91. PubMed ID: 25310142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of comorbid attention-deficit/hyperactivity disorder and anxiety in children: processes of change.
    Jarrett MA
    Psychol Assess; 2013 Jun; 25(2):545-555. PubMed ID: 23397930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
    Abikoff H; McGough J; Vitiello B; McCracken J; Davies M; Walkup J; Riddle M; Oatis M; Greenhill L; Skrobala A; March J; Gammon P; Robinson J; Lazell R; McMahon DJ; Ritz L;
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):418-27. PubMed ID: 15843763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.